Ultragenyx Reports Third Quarter 2026 Financial Results, Announces Substantial Expense Reductions, and Reaffirms Profitability in 2027—Ultragenyx Pharmaceutical Inc.
Ultragenyx Ultragenyx shrinks workforce and axes assets to halve R&D spend Fierce Biotech Ultragenyx to lay off 20% of employees, scrap a Wilson disease gene therapy Endpoints News Ultragenyx Pharmaceutical (NASDAQ:RARE) Issues Quarterly Earnings Results…
The report was published on 03 de novembro de 2026 às 18:01 by Ultragenyx and is part of the Business coverage.
Quick answers
Who reported this story?
It was first reported by Ultragenyx on 03 de novembro de 2026 às 18:01.
What is the category?
It is filed under Business on Rio Warzone News.
